Mycrodose Therapeutics is a US-Based pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases. The company is in the parallel development of two of its four core technologies; a psilocybin transdermal delivery system, Ketamine oral mucosa delivery system.
Mindstate Design Labs is a preclinical-stage biotechnology company focused on creating psychedelic-inspired therapeutics to address challenging mental health conditions. The company employs a unique platform that combines natural history and computational methods to forecast the acute effects of serotonergic agonists on humans. This innovative approach allows healthcare institutions to explore altered states of consciousness as potential treatments for various mental and behavioral health disorders. By developing these advanced therapeutics, Mindstate Design Labs aims to offer new solutions for individuals suffering from intractable mental health issues.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.